BIO-Europe Spring® 2016: Strategic unit at MD Anderson forges creative alliances

June 22, 2016
Shara Avis, business development specialist at MD Anderson Cancer Center—a world-renown research center—speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about how the center's strategic industry ventures unit is connecting companies with the research facility in a new way. During the BIO-Europe Spring partnering conference in Stockholm, Sweden, they discuss what the strategic industry unit has achieved so far and how it is targeting creative alliances to advance cancer therapies.
Previous Video
BIO-Europe® is where great biotech partnerships begin
BIO-Europe® is where great biotech partnerships begin

BIO-Europe 2016® | November 7-9 in Cologne, Germany | http://www.ebdgroup.com/bioeurope BIO-Europe® is Eur...

Next Video
BIO-Europe Spring® 2016: How to get Takeda Ventures to notice your startup
BIO-Europe Spring® 2016: How to get Takeda Ventures to notice your startup

Dr. Ilan Zipkin, senior investment director at Takeda Ventures, talks with Mike Ward, global director of co...